Physician profile
David B Nelles
NPI 1760710610
$34,939.49
in general payments reported to CMS, 2019-2025
15 companies · $954 in 2025
The $954 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,745 · 2020: $6,620 · 2021: $12K · 2022: $1,515 · 2023: $6,428 · 2024: $784 · 2025: $954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,179 · Food and Beverage: $3,988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,178.71 |
| Food and Beverage | $3,987.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart USA INC | $20,207.42 | 2019-2025 | Perla C, Perla Tl, Perla Tl Mis |
| Corelink, LLC | $11,854.76 | 2019-2023 | |
| Alphatec Spine, INC | $2,316.56 | 2021-2022 | |
| Medtronic, INC. | $185.71 | 2021-2025 | Prestige LP Cervical Disc System, Anteralign Spinal System With Titan Nanolock Surface Technology, Osteocool Rf Ablation System |
| Medtronic USA, INC. | $92.25 | 2020 | |
| Nuvasive, INC. | $61.87 | 2022 | |
| Orthofix Medical, INC. | $59.44 | 2024 | Spinal-Stim |
| Stryker Corporation | $26.97 | 2019 | |
| Xtant Medical INC | $24.28 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $21.42 | 2024 | |
| Team_makena_llc | $20.00 | 2019 | |
| Heron Therapeutics, INC. | $19.02 | 2021 | |
| Spineology INC. | $18.90 | 2019 | |
| Si-Bone, INC. | $17.99 | 2019 | |
| Providence Medical Technology, INC. | $12.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Nelles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.